FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Fresenius Kabi Recalls Ivenix Infusion Device

Fresenius Kabi recalls its Ivenix Infusion System due to a leak in the device that allows fluid to enter the administration set loading area.

latest-news-card-1
Federal Register

Info Collection on Rapid Response Surveys

Federal Register notice: FDA seeks comments on an information collection extension entitled Rapid Response Surveys.

latest-news-card-1
Federal Register

2 EUAs for Ebola Tests Withdrawn

Federal Register notice: FDA revokes the emergency use authorizations issued to BioFire Defense for the FilmArray NGDS BT‐E Assay, and Biocartis...

latest-news-card-1
Medical Devices

North American Diagnostics Illegal Covid Tests

FDA warns Holly Hill, FL-based North American Diagnostics it is illegally manufacturing and distributing adulterated and misbranded Covid-19 test kits...

latest-news-card-1
Human Drugs

Radiation Syndrome Drug Development Guidance

FDA publishes a draft guidance with information and recommendations to assist in developing drugs to prevent or treat acute radiation syndrome.

latest-news-card-1
Human Drugs

NCI Sees Revumenib Promise for Some Leukemias

The National Cancer Institute says Syndax Pharmaceuticals revumenib shows promise in treating some acute myeloid leukemias.

latest-news-card-1
Human Drugs

FDA Cautions Compounders on Bulk Sources

FDA says drug compounders should be sure the active pharmaceutical ingredients and excipients they use have been evaluated by their suppliers for puri...

latest-news-card-1
Human Drugs

FDA Drug Inspections Slow to Recover: Analysis

ProPublica says FDA foreign drug manufacturer inspections remain well below pre-pandemic inspection levels.

latest-news-card-1
Human Drugs

Guidance Shows Importance of Sponsor Oversight: Attorneys

Sidley attorneys say a new FDA final guidance on a risk-based approach to clinical trial oversight is significant for trial sponsors.

latest-news-card-1
Human Drugs

Generic Mifepristone Maker Sues FDA

Generic mifepristone maker GenBioPro sues FDA to block the agency from taking any actions against the company if a pending court order under review by...